Arax Advisory Partners’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$392K Buy
18,883
+18,205
+2,685% +$403K ﹤0.01% 1810
2026
Q1
$15.8K Buy
678
+470
+226% +$14.6K ﹤0.01% 2219
2025
Q4
$9.21K Sell
208
-2,452
-92% -$138K ﹤0.01% 2513
2025
Q3
$195K Buy
2,660
+2,544
+2,193% +$166K ﹤0.01% 1275
2025
Q2
$7.12K Buy
+116
New +$6.47K ﹤0.01% 2109
2024
Q4
Sell
-8
Closed -$349 2509
2024
Q3
$349 Hold
8
﹤0.01% 2454
2024
Q2
$224 Buy
+8
New +$211 ﹤0.01% 2430

Other funds holding DOCS

Arax Advisory Partners's DOCS Position: Q2 2026 in Review

Arax Advisory Partners increased its Doximity (DOCS) stake by 2,685% in Q2 2026, buying an estimated $403K and bringing the position to 18,883 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #1810.

Arax Advisory Partners first reported a position in DOCS in Q2 2024 and has held it in 7 quarters since. 358 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Arax Advisory Partners held 18,883 shares of Doximity worth $392K as of Q2 2026.
  • Arax Advisory Partners bought 18,205 Doximity shares in Q2 2026, an estimated $403K.
  • Doximity made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1810 holding.
  • Arax Advisory Partners first reported a position in Doximity in Q2 2024 and has held it in 7 quarters since.
  • 358 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.